Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
797.50    38.50 (5.07%)
Bid:
791.50
Ask:
804.00
Spread: 12.50 (1.579%)
Market Cap: £908.68m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Director/PDMR Shareholding

18 Nov 2019 07:00

RNS Number : 6602T
Fevertree Drinks PLC
18 November 2019
 

18 November 2019

Fevertree Drinks plc

Grant of Options

Fevertree Drinks plc (the "Company") announces the grant of options over a total of 64,466 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company with an exercise price of 0.25 pence.

On 8th May 2019, the following options were issued to the Company's Executive Directors, pursuant to the Company's Long Term Incentive Plan ("LTIP"):

Name

Title

Number of share options granted

Performance period

Vesting period

Exercise price

Tim Warrillow

Chief Executive Officer

39,240

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

Andy Branchflower

Finance Director

25,226

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

 

The number of Ordinary Shares stated is the maximum number that could be issued to each Executive Director upon full satisfaction of the performance conditions attached to the 2019 awards.

 

The performance conditions are based on the achievement of targets linked to the Company's FY2021 turnover (as regards 75% of each award) and FY2021 adjusted EBITDA (as regards 25% of each award)

 

Taking account of previous grants, the total number of unvested options held by the Executive Directors detailed in this announcement, pursuant to the Company's LTIP, is as follows:

 

Tim Warrillow - 135,123 share options

Andy Branchflower - 75,395 share options

 

This includes the awards granted in 2017 and 2018, further details of which have been disclosed in the relevant Directors Remuneration Report.

 

For further information:

 

Fevertree Drinks plc

 +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director

Numis Securities - Nominated Adviser and Broker

+44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker

+44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson

 

 

 

Brunswick Group

+44 (0)20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. Tim Warrillow

2. Andy Branchflower

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

b)

LEI

2138007AJRLHRVQZLD07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

Identification code

GB00BRJ9BJ26

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

1. 0.25p

2. 0.25p

1. 39,240

2. 25,226

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

8th May 2019

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDGBDBCSBBGCR
Date   Source Headline
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20252:11 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSCommencement of share buyback programme
10th Feb 20251:35 pmRNSHolding(s) in Company
7th Feb 20254:35 pmRNSHolding(s) in Company
7th Feb 20254:07 pmRNSHolding(s) in Company
7th Feb 20254:05 pmRNSHolding(s) in Company - correction
6th Feb 202511:39 amRNSHolding(s) in Company
5th Feb 20255:39 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSCompletion of Share Issuance to Molson Coors
3rd Feb 202512:20 pmRNSStandard form for notification of major holdings
30th Jan 20253:01 pmRNSDirector/PDMR Shareholding
30th Jan 20257:02 amRNSUS Strategic Partnership with Molson Coors
20th Jan 20257:00 amRNSAppointment Of Corporate Broker
6th Jan 20252:15 pmRNSStandard form for notification of major holdings
2nd Dec 202411:47 amRNSStandard form for notification of major holdings
2nd Dec 20247:00 amRNSBlock Listing Return
2nd Dec 20247:00 amRNSTotal Voting Rights
28th Nov 20245:12 pmRNSStandard form for notification of major holdings
18th Sep 20242:42 pmRNSStandard form for notification of major holdings
12th Sep 20247:00 amRNSFY24 Interim Results to 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
6th Jun 20241:29 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Trading Statement
3rd Jun 20247:00 amRNSBlock Listing Return
3rd Jun 20247:00 amRNSTotal Voting Rights
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.